BioMarin Pharmaceuticals BMRN Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's payments to acquire property, plant, and equipment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's payments to acquire property, plant, and equipment?
- BioMarin Pharmaceuticals (BMRN) reported payments to acquire property, plant, and equipment of $20.92M in Q1 2026.
- How has BioMarin Pharmaceuticals's payments to acquire property, plant, and equipment changed year-over-year?
- BioMarin Pharmaceuticals's payments to acquire property, plant, and equipment increased by 24.8% year-over-year, from $16.77M to $20.92M.
- What is the long-term trend for BioMarin Pharmaceuticals's payments to acquire property, plant, and equipment?
- Over 4 years (2021 to 2025), BioMarin Pharmaceuticals's payments to acquire property, plant, and equipment has grown at a 1.9% compound annual growth rate (CAGR), from $95.58M to $103.04M.